Ocular manifestations in hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): A case-series

REFERENCES

• Sutton, H. Epistaxis as indication of impaired nutrition and of degeneration of the vascular system. Med. Mirror. 1864;1:769.
   Google Scholar
• Rendu, M. Epistaxis repetees chez un sujet Pasteur de petits angiomes cutanes et muceux. Bull. Mem. Soc. Med. Hop. 1869;13:731.
   Google Scholar
• Weber, F. Multiple hereditary developmental angiomata of the skin and the mucous membranes associated with recurring haemorrhages. Lancet. 1907;2:160.
   Google Scholar
• Gallione CJ, Repetto GM, Legius E, et al. A combined syndrome of juvenile polyposis and hereditary haemorrhagic telangiectasia associated with mutations in MADH4 (SMAD4). Lancet. 2004;363:852–859
   PubMed Web of Science ®Google Scholar
• Letteboer TGW, Mager JJ, Snijder, et al. Genotype-phenotype relationship in hereditary hemorrhagic telangiectasia. J Med Genet. 2006;43:371–377.
   PubMed Web of Science ®Google Scholar
• Cole SG, Begbie ME, Wallace GM, et al. A new locus for hereditary hemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet. 2005;42:577–582
   PubMed Web of Science ®Google Scholar
• Letteboer TG, Zewald RA, Kamping EJ, et al. Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients. Hum Genet. 2005;116:8–16.
   PubMed Web of Science ®Google Scholar
• Lesca G, Plauchu H, Coulet F, et al. Molecular screening of ALK1/ACVRL1 and ENG genes in hereditary hemorrhagic telangiectasia in France. Hum Mutat. 2004;23:289–299.
   PubMedGoogle Scholar
• Shovlin CL, Guttmacher AE, Buscarini E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000;91:66–67.
   PubMed Web of Science ®Google Scholar
• Geisthoff UW, Hille K, Ruprecht KW, et al. Prevalence of ocular manifestations in hereditary hemorrhagic telangiectasia. Graefes Arch Clin Exp Ophthalmol. 2007;245:1141–1144.
   PubMedGoogle Scholar
• Vase I, Vase P. Ocular lesions in hereditary hemorrhagic telangiectasia.Acta Ophthalmol. 1979;57:1084.
   PubMed Web of Science ®Google Scholar
• Knox FA, Frazer DG. Ophthalmic presentation of hereditary hemorrhagic teleangiectasia. Eye. 2004;18:947–949.
   PubMedGoogle Scholar
• Brant AM, Schachat AP, White RI. Ocular manifestations in hereditary hemorragic telangiectasia (Rendu-Osler-Weber Disease). Am J Ophthalmol. 1989;107:642–646.
   PubMedGoogle Scholar
• Mahmoud TH, Deramo VA, Kim T, et al. Intraoperative choroidal hemorrhage in the Osler-Rendu-Weber syndrome. Am J Ophthalmol. 2002;133:282–284.
   PubMedGoogle Scholar
• Karissa L., Hackeleton. Acute visual loss as the presenting complaint of hereditary hemorragic telangiectasia. J Am Board Fam Med. 2006;19:637–40.
   PubMedGoogle Scholar
• Mennel S, Hoerle S, Meyer CH. Photodynamic therapy in symptomatic parafoveal telangiectasia secondary to Osler-Rendu-Weber disease. Acta Ophthalmol Scand. 2006;84:273–275.
   PubMedGoogle Scholar
• Pizzamiglio-Martin C, Gil-Cazorla R, Guzman-Blazquez J. Ophthalmologic diagnosis of hereditary hemorrhagic telangiectasia or Rendu-Osler-Weber disease. Arch Soc ESP Ophtalmol. 2008;83:381–384.
   PubMedGoogle Scholar
• Francois J. L’angiomatose hemorragique familiale et ses complications oculaires. Arch Ophthalmol. 1938;2: 245.
   Google Scholar
• Davis DG, Smith JL. Retinal involvement in hereditary hemorrhagic telangiectasia. Arch Ophthalmol. 1971;85:618–623.
   PubMedGoogle Scholar
• Georgiou T, Qureshi SH, Chakrabarty A, et al. Chororidal teleangiectasia in a patient with hereditary hemorrhagic telangiectasia. Eye. 2002;16:92–4.
   PubMedGoogle Scholar
• Majji AB, Hayashi A, Kim HC, et al. Inhibition of choriocapillaris regeneration with genistein. Invest Ophthalmol Vis Sci. 1999;40:1477–1486.
   PubMedGoogle Scholar
• Korte GE, Repucci V, Henkind P. RPE destruction causes choriocapillary atrophy. Invest Ophthalmol Vis Sci. 1984;25:1135–1145.
   PubMed Web of Science ®Google Scholar
• Friedman, E. A hemodynamic model of the pathogenesis of age-related macular degeneration. Am J Ophthalmol. 1997;124:677–682.
   PubMed Web of Science ®Google Scholar
• Harris A, Chung HS, Ciulla TA, Kagemann L. Progress in measurement of ocular blood flow and relevance to our understanding of glaucoma and age-related macular degeneration. Prog Retin Eye Res. 1999;18:669–687.
   PubMedGoogle Scholar
• Pauleikhoff D, Chen JC, Chisholm IH, et al. Choroidal perfusion abnormality with age-related Bruch’s membrane change. Am J Ophthalmol. 1990;109:211–217.
   PubMed Web of Science ®Google Scholar
• Zhao J, Frambach DA, Lee PP, et al. Delayed macular choriocapillary circulation in age-related macular degeneration. Int Ophthalmol. 1995;19:1–12.
   PubMed Web of Science ®Google Scholar
• Guttmacher AE, Marchuk DA, White RI Jr. Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995;333:918–924.
   PubMed Web of Science ®Google Scholar
• Walshe TE. TGF-beta and microvessel homeostasis. Microvasc Res. 2010;80:166–173.
   PubMedGoogle Scholar
• Schlingemann RO. Role of growth factors and the wound healing response in age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2004;242:91–101.
   PubMed Web of Science ®Google Scholar
• Massa JM, de Vloo N, Jamotton L. Les manifestations oculaires des hemopathies. Bull Soc Belg Ophtalmol. 1966;142:317–338.
   Google Scholar
• Pardali E, Goumans MJ, Ten Dijke P. Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol. 2010 Jul 23.
   PubMedGoogle Scholar